ProMIS Neurosciences, Inc.
PMN
$9.75
$0.040.36%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | 9.37M | 9.80M | 8.75M | -- |
| Gross Profit | -- | -9.37M | -9.80M | -8.75M | -- |
| SG&A Expenses | 1.67M | 1.40M | 1.95M | 1.43M | 2.00M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.64M | 10.77M | 11.75M | 10.18M | 7.46M |
| Operating Income | -8.64M | -10.77M | -11.75M | -10.18M | -7.46M |
| Income Before Tax | -8.24M | -10.67M | -11.58M | -10.12M | -7.35M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -8.24M | -10.67M | -11.58M | -10.12M | -7.35M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -8.24M | -10.67M | -11.58M | -10.12M | -7.35M |
| EBIT | -8.64M | -10.77M | -11.75M | -10.18M | -7.46M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -1.26 | -4.14 | -5.93 | -7.26 | -5.27 |
| Normalized Basic EPS | -0.79 | -2.59 | -3.71 | -4.54 | -3.29 |
| EPS Diluted | -1.26 | -4.19 | -6.00 | -7.26 | -5.27 |
| Normalized Diluted EPS | -0.79 | -2.59 | -3.71 | -4.54 | -3.29 |
| Average Basic Shares Outstanding | 6.53M | 2.58M | 1.95M | 1.39M | 1.39M |
| Average Diluted Shares Outstanding | 6.53M | 2.58M | 1.95M | 1.39M | 1.39M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |